Pathology labs are getting a digital overhaul thanks to Techcyte, which recently announced it has raised $15.0M in investment capital. The company, founded in 2013, offers a unified pathology platform designed to digitize lab workflows and integrate AI tools, aiming to improve the efficiency and accuracy of diagnostic testing.
Techcyte's broader mission is to leverage artificial intelligence to positively impact the health of humans, animals, and the environment. It achieves this by collaborating with a network of partners to deliver its clinical and anatomic pathology platform to labs and clinics globally.
